Cart

Unlocking potential with the best learning and research solutions

Look Inside Essential Neuropharmacology

Essential Neuropharmacology
The Prescriber's Guide

2nd Edition

CAD$113.95 (M)

Authors:
Stephen D. Silberstein, Thomas Jefferson University, Philadelphia
Michael J. Marmura, Thomas Jefferson University, Philadelphia
Hsiangkuo Yuan, Thomas Jefferson University, Philadelphia

Date Published: November 2015
availability: In stock
format: Paperback
isbn: 9781107485549

Rate & review

CAD$ 113.95 (M)
Paperback

Add to cart Add to wishlist

Other available formats:
eBook

Looking for an examination copy?

This title is not currently available for examination. However, if you are interested in the title for your course we can consider offering an examination copy. To register your interest please contact [email protected] providing details of the course you are teaching.

Description

Contents

Resources

Courses

About the Authors

Essential Neuropharmacology: The Prescriber's Guide reviews the full range of medications used by neurologists in clinical practice. Expert knowledge is given about the best use of medications in patient care. Each drug listing contains the full range of indications, their advantages and disadvantages, and tips for dosing and avoiding adverse effects. Evidence is taken from recent clinical trials, which helps the reader relate the drug descriptions to everyday clinical practice. Where appropriate, off-label uses are also described. The detailed descriptions of each medication enable the user to make quick and informed decisions with the confidence they need to serve the clinical needs of their patients effectively. The new edition is fully updated throughout. Major new additions include neuro-oncology drugs, new multiple sclerosis agents, sleep medications and new formulations. This book is an essential, user-friendly reference suitable for neurologists at all stages of their careers.
- Provides the most complete and up-to-date summary of the practical use of neurologic drugs – ensures currency
- Uniform format and design – allows readers quickly to access relevant information in a clinical setting
- Expanded to include new drugs and formulations, including neuro-oncology drugs, new multiple sclerosis agents, medications used for sleep - comprehensive for modern neurologic practice
Read more
Reviews & endorsements
Review of previous edition: '… [this] book is ideal for use in the clinical environment and the authors have released an 'App' to facilitate this use – a well-judged addition … The interface is intuitive, even for the 'smartphone' novice.' Advances in Clinical Neuroscience and Rehabilitation

Customer reviews

Not yet reviewed
Be the first to review

Log in to review

Review was not posted due to profanity
×

, create a review

(If you're not , sign out)

Please enter the right captcha value

Please enter a star rating.

Your review must be a minimum of 12 words.

How do you rate this item?

Reviews must contain at least 12 words about the product.

×

Product details
- Edition: 2nd Edition
- Date Published: November 2015
- format: Paperback
- isbn: 9781107485549
- length: 480 pages
- dimensions: 229 x 140 x 29 mm
- weight: 1.16kg
- availability: In stock
Table of Contents
Introduction
List of icons
Acknowledgements
1. Acetazolamide
2. Alemtuzumab
3. Almotriptan
4. Alteplase
5. Amantadine
6. Amifampridine
7. Amitriptyline
8. Apixaban
9. Apomorphine
10. Aprepitant
11. Aripiprazole
12. Armodafinil
13. Aspirin (acetylsalicylic acid)
14. Azathioprine
15. Baclofen
16. Benztropine
17. Bevacizumab
18. Botulinum toxin type A
19. Botulinum toxin type B
20. Bromocriptine
21. Bupropion
22. Carbamazepine
23. Carisoprodol
24. Carmustine
25. Chlorpromazine
26. Citalopram
27. Clobazam
28. Clonazepam
29. Clonidine
30. Clopidogrel
31. Clozapine
32. Corticotropin
33. Cyclobenzaprine
34. Cyclophosphamide
35. Cyclosporine (ciclosporin)
36. Cyproheptadine
37. Dabigatran etexilate
38. Dalfampridine
39. Dantrolene
40. Desvenlafaxine
41. Dexamethasone
42. Dextromethorphan/quinidine
43. Diazepam
44. Diclofenac
45. Dihydroergotamine (DHE)
46. Dimethyl fumarate
47. Dipyridamole/aspirin
48. Donepezil
49. Droperidol
50. Droxidopa
51. Duloxetine
52. Edoxaban
53. Edrophonium
54. Eletriptan
55. Entacapone
56. Escitalopram
57. Eslicarbazepine acetate
58. Ethosuximide
59. Everolimus
60. Ezogabine
61. Felbamate
62. Fingolimod
63. Flunarizine
64. Frovatriptan
65. Gabapentin
66. Galantamine
67. Glatiramer acetate
68. Guanfacine
69. Haloperidol
70. Heparin
71. Intravenous immunoglobulin (iVIg)
72. Indomethacin
73. Interferon-β (1a and 1b)
74. Lacosamide
75. Lamotrigine
76. Levetiracetam
77. Levodopa and carbidopa
78. Levomilnacipran
79. Lidocaine
80. Lithium
81. Mannitol
82. Meclizine
83. Memantine
84. Metoclopramide
85. Metaxalone
86. Methocarbamol
87. Methotrexate
88. Methylergonovine
89. Methysergide
90. Mexiletine
91. Milnacipran
92. Mirtazapine
93. Mitoxantrone
94. Modafinil
95. Mycophenolate mofetil
96. Nabiximols
97. Naratriptan
98. Natalizumab
99. Netupitant/palonosetron
100. Nimodipine
101. Nortriptyline
102. Olanzapine
103. Ondansetron
104. Oxcarbazepine
105. Penicillamine
106. Perampanel
107. Phenytoin and fosphenytoin
108. Pizotifen
109. Pramipexole
110. Prednisone
111. Pregabalin
112. Primidone
113. Prochlorperazine
114. Propranolol
115. Pyridostigmine
116. Quetiapine
117. Quinine sulfate
118. Ramelteon
119. Reserpine
120. Riluzole
121. Rituximab
122. Rivaroxaban
123. Rivastigmine
124. Rizatriptan
125. Ropinirole
126. Rotigotine transdermal system
127. Rufinamide
128. Sodium oxybate
129. Sumatriptan
130. Suvorexant
131. Tasimelteon
132. Temozolomide
133. Teriflunomide
134. Tetrabenazine
135. Tiagabine
136. Timolol
137. Tizanidine
138. Topiramate
139. Trientine hydrochloride
140. Trihexyphenidyl
141. Valproic acid and derivatives (DPX)
142. Venlafaxine
143. Verapamil
144. Vigabatrin
145. Vilazodone
146. Vortioxetine hydrobromide
147. Warfarin
148. Zolmitriptan
149. Zonisamide
List of abbreviations
Index by drug name
Index by use
Index by class.
Look Inside
Authors
Stephen D. Silberstein, Thomas Jefferson University, Philadelphia
Stephen D. Silberstein is a Professor at Jefferson Medical College, Thomas Jefferson University, and Director, Jefferson Headache Center, Thomas Jefferson University Hospital, Philadelphia, PA, USA.
Michael J. Marmura, Thomas Jefferson University, Philadelphia
Michael J. Marmura is Assistant Professor in the Department of Neurology, Jefferson Headache Center, Thomas Jefferson University, Philadelphia, PA, USA.
Hsiangkuo Yuan, Thomas Jefferson University, Philadelphia
Hsiangkuo Yuan is a visiting scholar in the Department of Neurology, Thomas Jefferson University Hospital, Philadelphia, PA, USA.
Consultant Editor
Stephen M. Stahl, University of California, San Diego
Stephen M. Stahl is Adjunct Professor of Psychiatry at the University of California, San Diego, CA, USA, and Honorary Visiting Senior Fellow at the University of Cambridge, Cambridge, UK.